# Pulmonary Vein Isolation With Versus Without Continued Antiarrhythmic Drug Treatment in Subjects With Recurrent Atrial Fibrillation

> **NCT02475642** · PHASE4 · UNKNOWN · sponsor: **VZW Cardiovascular Research Center Aalst** · enrollment: 152 (actual)

## Conditions studied

- Atrial Fibrillation

## Interventions

- **OTHER:** PVI-ADT
- **OTHER:** PVI+ADT

## Key facts

- **NCT ID:** NCT02475642
- **Lead sponsor:** VZW Cardiovascular Research Center Aalst
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-03
- **Primary completion:** 2016-08
- **Final completion:** 2016-08
- **Target enrollment:** 152 (ACTUAL)
- **Last updated:** 2016-04-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02475642

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02475642, "Pulmonary Vein Isolation With Versus Without Continued Antiarrhythmic Drug Treatment in Subjects With Recurrent Atrial Fibrillation". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02475642. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*